BioSig and Streamex Secure $1.1 Billion for Gold Tokenization Push

BioSig Technologies, Inc. and Streamex Exchange Corporation have secured up to $1.1 billion in growth financing to support their strategic shift into onchain commodities, with a primary focus on gold. This significant capital raise is aimed at launching a gold-backed treasury model and scaling their tokenization platform for real-world assets (RWAs) such as gold and other commodities.

The financing package includes $100 million in senior secured convertible debentures, which accrue 4% interest and are convertible into common shares, providing holders with a substantial equity position. Additionally, the company has secured a $1 billion equity line of credit, allowing it to issue new shares and sell up to $1 billion of common stock to investors over the next 36 months. This financial maneuver is part of a broader strategy to leverage the growing trend of tokenized assets, which are projected to become a multitrillion-dollar market in the coming years.

BioSig and Streamex are positioning themselves as a gold treasury company, differentiating their approach from other firms that have pivoted to a crypto treasury strategy by investing in tokens like bitcoin and Ethereum's ether. The merged entity plans to hold physical gold through a top-tier bullion bank and denominate much of its balance sheet in gold rather than fiat currency. This strategy is designed to capitalize on the stability and trust associated with gold while benefiting from the innovation and scalability of blockchain technology.

Streamex, which operates on the Solana blockchain, will issue tokens backed by gold and other commodities through its platform. This initiative aims to unlock liquidity, transparency, and accessibility across the $142 trillion commodities market. By combining the value of physical gold with the innovation of blockchain, BioSig and Streamex are building a company grounded in what they believe to be the world’s most trusted store of value while enabling a scalable, high-return business model through tokenization.

The company's CEO and Streamex co-founder, Henry McPhie, emphasized the mission to unlock liquidity, transparency, and accessibility across the commodities market. This milestone in securing $1.1 billion in financing is seen as just the beginning of their ambitious plans. The strategic pivot into gold tokenization is expected to drive significant growth and innovation in the commodities market, leveraging the strengths of both traditional assets and cutting-edge technology.

BioSig and Streamex are entering a competitive landscape with existing players like Paxos Gold (PAXG) and Tether Gold (XAUT), which are already exploring tokenized gold. Both PAXG and XAUT are backed by physical gold stored in vaults. The new company’s approach, however, will be slightly different. Streamex aims to use its balance sheet capital to seed liquidity into creating gold and structured product gold-related tokens. This approach allows the company to potentially purchase gold and gold-like assets, tokenize those assets, and then bring them to market.

The company expects to generate revenue from its tokenized gold fund through four routes: origination fees, tokenization fees, secondary trading fees, and spread income. The plan is to bring the first tokenized gold asset to market by early 2026. This strategic move positions BioSig and Streamex at the forefront of the growing trend of tokenized commodities, which, although currently a small portion of the overall tokenization market, is expected to grow significantly in the coming years.

Tokenized commodities represent a small but growing segment of the real-world asset (RWA) tokenization market. According to available data, tokenized commodities account for 6.6% of the overall tokenization market, with a total market cap of $1.62 billion. Paxos Gold and Tether Gold together account for 98.9% of the total market value of tokenized commodities, highlighting the dominance of these two players in the current landscape. The entry of BioSig and Streamex into this market could potentially disrupt the existing dynamics and bring new competition and innovation to the sector.